# A Prospective Pharmacodynamic Study of Rivaroxaban

> **NCT01743898** · — · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 65 (estimated)

## Conditions studied

- Blood Clot

## Interventions

- **DRUG:** Rivaroxaban
- **OTHER:** no anticoagulation

## Key facts

- **NCT ID:** NCT01743898
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-03
- **Final completion:** 2014-08
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01743898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01743898, "A Prospective Pharmacodynamic Study of Rivaroxaban". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01743898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*